Clinical trial
BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA
NCT00321178 · University Medical Center Groningen, Other · Completed
Key facts
| NCT number | NCT00321178 |
|---|---|
| Title | BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA |
| Official title | Randomised Trial for Early Lesions Caused by M. Ulcerans - Comparison Between 8 Weeks Streptomycin and Rifampicin (SR), or 4 Weeks SR Followed by 4 Weeks R Plus Clarithromycin |
| Acronym | BURULICO |
| Lead sponsor | University Medical Center Groningen, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Buruli Ulcer, Mycobacterium Ulcerans |
| Intervention type | Drug |
| Interventions | SR4 - switch to CR4 |
| Enrollment | 151 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | May 3, 2006 |
| Last update posted | Jun 30, 2010 |
| Countries | Ghana |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: